{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/management/yellow-fever/","result":{"pageContext":{"chapter":{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever","depth":2,"htmlHeader":"<!-- begin field 15143ee8-913c-4d42-ba0e-e62c9930a029 --><h2>Scenario: Yellow fever</h2><!-- end field 15143ee8-913c-4d42-ba0e-e62c9930a029 -->","summary":"Covers advice for people travelling to areas endemic with yellow fever, and details of how to find yellow fever vaccination centres.","htmlStringContent":"<!-- begin item 3d280ff7-ab8c-495b-8e93-52919da7f3cd --><!-- begin field 07a20989-ef48-470f-82c3-acd900ab524b --><p>From age 9 months onwards.</p><!-- end field 07a20989-ef48-470f-82c3-acd900ab524b --><!-- end item 3d280ff7-ab8c-495b-8e93-52919da7f3cd -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"7cc2017a-925f-5d06-a499-4a2425dc5475","slug":"indications-for-vaccine","fullItemName":"Indications for vaccine","depth":3,"htmlHeader":"<!-- begin field 801b0415-db43-42e1-a9cd-43ddbcb886bc --><h3>Indications for vaccine</h3><!-- end field 801b0415-db43-42e1-a9cd-43ddbcb886bc -->","summary":null,"htmlStringContent":"<!-- begin item acd0b854-4b42-44ba-96f7-abd6b796cd3e --><!-- begin field ef00a73a-96d9-482f-94e5-82993ae00d7c --><ul><li><strong>Yellow fever vaccination is only available from a designated Yellow Fever Vaccination Centre:</strong><ul><li>For the location of vaccination centres, see the Yellow Fever Vaccination Programme section of the <a href=\"http://www.nathnac.org/\" data-hyperlink-id=\"e30ea284-03b7-47c5-b932-a93100aab575\">NaTHNaC</a> website.</li></ul></li><li><strong>Rare severe adverse events have been associated with yellow fever vaccination.</strong> It is therefore important to make a risk assessment prior to administering the vaccine, taking into account the person's age, travel destination, itinerary, season of travel, and planned activities. In general, the risk from yellow fever for travel to a yellow fever-endemic region outweighs the risks associated with the vaccine. </li><li><strong>The following groups should be immunized:</strong><ul><li><strong>People aged 9 months or older who are travelling to <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/background-information/where-these-diseases-are-prevalent/\">countries</a> that require an International Certificate of Vaccination or Prophylaxis (ICVP) for entry.</strong> An ICVP is required for travellers coming from or transiting through countries where yellow fever occurs.</li><li><strong>People aged 9 months or older who are travelling to, or will be living in, infected areas or </strong><a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/background-information/where-these-diseases-are-prevalent/\">countries</a><strong> in the yellow fever endemic zone, even if these countries do not require evidence of immunization on entry.</strong><ul><li>For up-to-date information on countries and areas affected by yellow fever, see the <a href=\"http://www.travelhealthpro.org.uk/\" data-hyperlink-id=\"13f16d6e-ac28-466e-bd5d-a93100aab7fd\">TravelHealthPro</a> website.</li></ul></li></ul></li><li><strong>Infants aged 6–9 months should only be immunized if the risk is unavoidable;</strong> expert opinion should be sought in these situations. Infants below 6 months of age should not be vaccinated.</li><li><strong>People aged 60 years and older should only be immunized if there is a significant and unavoidable risk of acquiring yellow fever infection,</strong> such as travel to an area where there is a current or periodic risk of transmission. </li><li><strong>Note: travellers to endemic regions are also advised to use standard precautions to prevent mosquito bites, as yellow fever is transmitted to humans by <em>Aedes </em>mosquitoes.</strong></li></ul><!-- end field ef00a73a-96d9-482f-94e5-82993ae00d7c --><!-- end item acd0b854-4b42-44ba-96f7-abd6b796cd3e -->","subChapters":[{"id":"7374b8f8-cd95-5c07-a4fc-e374249d0453","slug":"basis-for-recommendation-d21","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 4d3d472a-c2f0-4894-bced-a2c3be7c6e24 --><h4>Basis for recommendation</h4><!-- end field 4d3d472a-c2f0-4894-bced-a2c3be7c6e24 -->","summary":null,"htmlStringContent":"<!-- begin item d21294a7-883d-4f75-9472-47ed9c69bfab --><!-- begin field 6b49e952-50b8-47d1-b796-94f7547d8559 --><p>The recommendations on indications for yellow fever vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 35: Yellow Fever</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020a</a>].</p><!-- end field 6b49e952-50b8-47d1-b796-94f7547d8559 --><!-- end item d21294a7-883d-4f75-9472-47ed9c69bfab -->","subChapters":[]}]},{"id":"c7506d8b-ed51-5b7c-adf3-2e20409699c2","slug":"available-vaccines-vaccination-schedules","fullItemName":"Available vaccines and vaccination schedules","depth":3,"htmlHeader":"<!-- begin field c7b084d9-7898-4bac-9118-c2e35c70abb5 --><h3>Available vaccines and vaccination schedules</h3><!-- end field c7b084d9-7898-4bac-9118-c2e35c70abb5 -->","summary":null,"htmlStringContent":"<!-- begin item 1328e057-45b9-48ed-aab6-4e671aaf4f0b --><!-- begin field 98ef3cef-efb1-47c7-8db6-c7baeae7f7d9 --><ul><li><strong>The yellow fever vaccine available in the UK (Stamaril<sup>®</sup>) is a live<em> </em>attenuated preparation.</strong><ul><li>It is administered as a single dose and confers immunity in 95–100% of recipients.</li><li>Immunization should be performed at least 10 days prior to travel to an endemic <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/background-information/where-these-diseases-are-prevalent/\">area</a> to allow protective immunity to develop and for an International Certificate of Vaccination (if required) to become valid.</li><li>For most people, a single dose of yellow fever vaccine appears to confer life-long protective immunity. </li><li>A booster dose after 10 years is recommended for people at persistent risk of contracting the disease who received their first yellow fever vaccination when aged less than 2 years old, during pregnancy, whilst infected with HIV or otherwise immunosuppressed, or before undergoing a bone marrow transplant. For further information, see <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/306941/Green_Book_Chapter_35_v3_3.pdf\" data-hyperlink-id=\"30c6f66c-9633-4cfb-92e8-a93100b688b1\">The Green Book</a>.</li></ul></li><li><strong>Note: the international yellow fever vaccination certificate becomes valid 10 days after primary vaccination. It remains valid for the life of the traveller.</strong></li></ul><!-- end field 98ef3cef-efb1-47c7-8db6-c7baeae7f7d9 --><!-- end item 1328e057-45b9-48ed-aab6-4e671aaf4f0b -->","subChapters":[{"id":"c59823a6-2f94-577c-80c0-d10014690dfe","slug":"basis-for-recommendation-f7d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field d3227e35-21f8-4455-9f32-3687c51a43d6 --><h4>Basis for recommendation</h4><!-- end field d3227e35-21f8-4455-9f32-3687c51a43d6 -->","summary":null,"htmlStringContent":"<!-- begin item f7d475ad-7be7-4f3c-bde5-457b7243f531 --><!-- begin field 91525ae1-d405-4ae2-b279-f3eadc6a492a --><ul><li>The information on available types of yellow fever vaccine and vaccination schedules is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 35: Yellow Fever</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020a</a>].</li></ul><!-- end field 91525ae1-d405-4ae2-b279-f3eadc6a492a --><!-- end item f7d475ad-7be7-4f3c-bde5-457b7243f531 -->","subChapters":[]}]},{"id":"ca1f378f-e2c8-5e6f-8103-f715d428f8b4","slug":"contraindications-to-vaccine","fullItemName":"Contraindications to vaccine","depth":3,"htmlHeader":"<!-- begin field 49a25495-247e-4f91-877b-d347cea9a49b --><h3>Contraindications to vaccine</h3><!-- end field 49a25495-247e-4f91-877b-d347cea9a49b -->","summary":null,"htmlStringContent":"<!-- begin item d1a7f4d5-891c-47b0-b382-3d9dc3a5b102 --><!-- begin field 574fd604-7202-4dd7-8445-6386b90968d6 --><ul><li><strong>Yellow fever vaccine should not be given to:</strong><ul><li>Infants aged 6 months or under.</li><li>People who have had a confirmed anaphylactic reaction to a previous dose of yellow fever vaccine.</li><li>People who have had a confirmed anaphylactic reaction to any of the components of the vaccine.</li><li>People who have had a confirmed anaphylactic reaction to egg.</li><li>People with thymus disorders.</li><li>People who are immunocompromised.</li><li>People aged 60 years or older who are travelling to areas where yellow fever vaccine is generally not recommended by the WHO. For information, see the <a href=\"https://travelhealthpro.org.uk/countries\" data-hyperlink-id=\"d42c7135-1c5c-4bee-a2b0-accb012bf949\">country-by-country guide to disease prevalence</a> on the <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/initial-assessment-advice/#information-sources-for-overseas-travel\">National Travel Health Network and Centre</a> (NaTHNaC) <a href=\"https://travelhealthpro.org.uk/\" data-hyperlink-id=\"c319178d-dd85-47aa-b015-accb012bf949\">Travel Health Pro</a> website.</li><li>People with a first-degree family history of yellow fever vaccine-associated viscerotropic disease (YEL-AVD) or yellow fever vaccine-associated neurological disease (YEL-AND) following vaccination that was not related to a known medical risk factor. <ul><li>Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) is a very rare syndrome of fever and multi-organ failure.</li><li>Yellow fever vaccine-associated neurological disease (YEL-AND) is a very rare pattern of neurological adverse events.</li><li>For further information, see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/yellow-fever/#adverse-effects\">Adverse effects</a>.</li></ul></li></ul></li><li><strong>Yellow fever vaccine should not generally be given to pregnant women because of the theoretical risk of fetal infection from the live virus vaccine. </strong>Pregnant women should therefore be advised not to travel to a high-risk area. However, when travel is unavoidable, the risk from the disease and the theoretical risk from the vaccine should be assessed on an individual basis.<ul><li>A patient information leaflet on use of <a href=\"http://www.medicinesinpregnancy.org/Medicine--pregnancy/Yellow-fever-vaccine/\" data-hyperlink-id=\"64f0d4ea-375d-44f2-97a0-a93c0069ea9d\">yellow fever</a> vaccine in pregnancy is available from the UK Teratology Information Service at <a href=\"http://www.medicinesinpregnancy.org/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"0a780bda-95c9-4d8f-8276-acd1009f6581\">www.medicinesinpregnancy.org</a>.</li></ul></li><li>If a yellow fever vaccine is required for a breastfeeding woman, seek specialist advice from the <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/initial-assessment-advice/#information-sources-for-overseas-travel\">National Travel Health Network and Centre</a> (NaTHNaC).<ul><li>There is some evidence of transmission of the live vaccine virus through breast milk to infants under 2 months of age.</li></ul></li><li><strong>Postpone yellow fever vaccination if the person has a current severe febrile illness.</strong><ul><li>Minor illness without fever or systemic upset is <em>not</em> a valid reason to postpone immunization.</li></ul></li><li><strong>Anyone who cannot receive a yellow fever vaccine and who must travel</strong> should be informed of the risk of yellow fever and instructed in strict mosquito bite avoidance measures.</li><li><strong>Anyone who cannot receive a yellow fever vaccine and is travelling to a country where an International Certificate of Vaccination and Prophylaxis against yellow fever is required for entry,</strong> should request that a letter of exemption is issued by the Yellow Fever Vaccination Centre or by the practitioner treating the person. </li></ul><!-- end field 574fd604-7202-4dd7-8445-6386b90968d6 --><!-- end item d1a7f4d5-891c-47b0-b382-3d9dc3a5b102 -->","subChapters":[{"id":"d3c48413-cfbf-5a2d-beef-2c9779e0f4c1","slug":"basis-for-recommendation-752","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 0f916dee-4061-4016-b5a7-b678a66ad9da --><h4>Basis for recommendation</h4><!-- end field 0f916dee-4061-4016-b5a7-b678a66ad9da -->","summary":null,"htmlStringContent":"<!-- begin item 752f2647-5d96-49ef-a7ff-de7b528a3c46 --><!-- begin field 34a4b71d-eed6-4838-b0d1-5d627d2425f6 --><p>The information on contraindications to yellow fever vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 35: Yellow fever </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020a</a>] and <em>Chapter 6: Contraindications and special considerations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2017a</a>].</p><!-- end field 34a4b71d-eed6-4838-b0d1-5d627d2425f6 --><!-- end item 752f2647-5d96-49ef-a7ff-de7b528a3c46 -->","subChapters":[]}]},{"id":"8954b47e-d56c-529e-8d45-52c3887aa526","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field f3f0eab5-f613-45e5-afca-e2e586260587 --><h3>Adverse effects</h3><!-- end field f3f0eab5-f613-45e5-afca-e2e586260587 -->","summary":null,"htmlStringContent":"<!-- begin item 938b6cf0-b764-4464-b1c0-b0ddb60345bf --><!-- begin field c97a42a4-8b6a-4f5a-835c-7c8bb4b4ab4e --><ul><li><strong>Adverse reactions following yellow fever vaccine are typically mild</strong> and consist of headache, myalgia, low-grade fever, and/or soreness at the injection site, and will occur in 10–30% of recipients.<ul><li>Injection-site reactions tend to occur from days 1–5 after immunization.</li></ul></li><li><strong>Systemic adverse effects also occur early but may last up to 2 weeks.</strong> Up to 1% of individuals may need to alter daily activities due to these.</li><li><strong>Rash, urticaria, bronchospasm, and anaphylaxis occur rarely</strong> (estimated to be 1.3 cases per 100,000 doses of vaccine).</li><li><strong>Post-vaccine encephalitis may occur rarely, particularly in infants </strong>(0.5–4 cases per 1000 infants under 6 months of age).</li><li><strong>Rarely, yellow fever vaccine-associated neurological disease (YEL-AND) may occur.</strong><ul><li>YEL-AND begins 2–56 days after vaccination with the onset of fever and headache that may progress to include one or more of: confusion, focal neurological deficits, coma, and Guillain–Barré syndrome. Most people recover completely. Almost all cases have occurred following primary vaccination (in people who have no underlying yellow fever immunity).</li></ul></li><li><strong>Rarely, yellow fever vaccine-associated viscerotropic disease (YEL-AVD) may occur.</strong><ul><li>YEL-AVD begins 1–18 days after vaccination with the onset of fever, malaise, headache, and myalgias that progress to hepatitis, hypotension, and multi-organ failure; death has occurred in more than 60% of reported cases. All cases have occurred following primary vaccination (in people without underlying yellow fever immunity).</li><li>In the reports of viscerotropic disease, 17% have had a history of thymus disease with subsequent thymectomy. Thus, people with thymus disorders should not receive yellow fever vaccine.</li></ul></li><li><strong>The overall reporting rate in the US of neurological and viscerotropic adverse events following yellow fever vaccination is as follows:</strong><ul><li>Neurological events — 8 cases per million doses.</li><li>Viscerotropic events — 3 cases per million doses.</li></ul></li><li><strong>For those who are aged 60 years or older, the risk of neurological and viscerotropic adverse events increases:</strong><ul><li>Neurological events — 22 cases per million doses.</li><li>Viscerotropic events — 12 cases per million doses.</li></ul></li></ul><!-- end field c97a42a4-8b6a-4f5a-835c-7c8bb4b4ab4e --><!-- end item 938b6cf0-b764-4464-b1c0-b0ddb60345bf -->","subChapters":[{"id":"1d906429-857b-5e0e-91c4-1f6a27fa9cf7","slug":"basis-for-recommendation-327","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 7db00019-94b5-4395-8cd0-aa22baf518d6 --><h4>Basis for recommendation</h4><!-- end field 7db00019-94b5-4395-8cd0-aa22baf518d6 -->","summary":null,"htmlStringContent":"<!-- begin item 32710664-0dd4-4d72-ae1c-10c8a56ed2d2 --><!-- begin field 89a26a64-deeb-4dd4-8fc8-4817a3aa3bc1 --><p>The information on adverse effects of yellow fever vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 35: Yellow Fever</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020a</a>].</p><!-- end field 89a26a64-deeb-4dd4-8fc8-4817a3aa3bc1 --><!-- end item 32710664-0dd4-4d72-ae1c-10c8a56ed2d2 -->","subChapters":[]}]},{"id":"a4c40f8a-6c34-56cc-b7c9-14262ae8db02","slug":"how-to-administer-yellow-fever-vaccine","fullItemName":"How to administer yellow fever vaccine","depth":3,"htmlHeader":"<!-- begin field a5f3d2c2-c013-493b-8675-a28bcb722682 --><h3>How to administer yellow fever vaccine</h3><!-- end field a5f3d2c2-c013-493b-8675-a28bcb722682 -->","summary":null,"htmlStringContent":"<!-- begin item 45f7c1c0-ae1a-445d-96ec-f926398de2d3 --><!-- begin field 8a018e4a-6aa0-4665-8477-f7770809cec5 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/yellow-fever/#contraindications-to-vaccine\">contraindications</a> to the vaccine.</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/yellow-fever/#adverse-effects\">adverse reactions</a> have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li><li>The vaccination site has been washed with soap and water if it is visibly dirty. </li></ul></li><li><strong>Yellow fever vaccine is usually given by intramuscular (IM) injection,</strong> into the upper arm in children and adults, or the anterolateral thigh in infants under 1 year of age. However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. </li><li><strong>Yellow fever vaccine can be given at the same time as most other vaccines.</strong> If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. <ul><li>However, yellow fever and measles, mumps, and rubella (MMR) vaccines should, where possible, be given at least 28 days apart.</li></ul></li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field 8a018e4a-6aa0-4665-8477-f7770809cec5 --><!-- end item 45f7c1c0-ae1a-445d-96ec-f926398de2d3 -->","subChapters":[{"id":"50233c78-a198-5e71-802a-7d3bb96f9992","slug":"basis-for-recommendation-f5d","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 56a1a1cb-58ce-4de0-8b12-322c3cbea4ef --><h4>Basis for recommendation</h4><!-- end field 56a1a1cb-58ce-4de0-8b12-322c3cbea4ef -->","summary":null,"htmlStringContent":"<!-- begin item f5d8f696-324a-45c8-8f01-36c10b4cd163 --><!-- begin field b6901896-6943-40c6-af6a-a06b48df94a9 --><p>The recommendations on administering yellow fever vaccine are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 35: Yellow fever</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020a</a>], <em>Chapter 2: Consent</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>], <em>Chapter 4: Immunisation procedures</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>], and <em>Chapter 8: Vaccine safety and adverse effects</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013g</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>].</li></ul><h5>Site of administration</h5><ul><li>In people over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>].</li></ul><h5>MMR and yellow fever vaccine administration</h5><ul><li>The recommendation not to co-administer these vaccines is based on evidence that this can lead to sub-optimal antibody responses to yellow fever, mumps and rubella antigens [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020a</a>].</li></ul><!-- end field b6901896-6943-40c6-af6a-a06b48df94a9 --><!-- end item f5d8f696-324a-45c8-8f01-36c10b4cd163 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}